Display options
Cite
Grassi M, Raffa S, Damiani VC, et al. Moderni orientamenti di terapia medica della colite ulcerosa. [Current orientation in medical management of ulcerative colitis]. Clin Ter. 1995;146(5):327-41
Grassi, M., Raffa, S., Damiani, V. C., & Fontana, M. (1995). Moderni orientamenti di terapia medica della colite ulcerosa. [Current orientation in medical management of ulcerative colitis]. La Clinica terapeutica, 146(5), 327-41.
Grassi, M, et al. "Moderni orientamenti di terapia medica della colite ulcerosa." [Current orientation in medical management of ulcerative colitis]. La Clinica terapeutica vol. 146,5 (1995): 327-41.
Grassi M, Raffa S, Damiani VC, Fontana M. Moderni orientamenti di terapia medica della colite ulcerosa. [Current orientation in medical management of ulcerative colitis]. Clin Ter. 1995 May;146(5):327-41. Italian. PMID: 7796565.
Copy Download .nbib Format: NLM
Share it on

Clin Ter. 1995 May;146(5):327-41.

[Current orientation in medical management of ulcerative colitis].

La Clinica terapeutica

[Article in Italian]
M Grassi, S Raffa, V C Damiani, M Fontana

Affiliations

  1. Università degli Studi di Roma La Sapienza, Istituto di Idrologia Medica.

PMID: 7796565

Abstract

Authors synthetically remind epidemiology, eziopathogenesis and clinic of ulcerative colitis; they after describe the drugs employed in therapy of disease, stressing the mechanism of action, efficacy, collateral effects. Authors remember the choice of cortisonic therapy in the acute and severe periods of disease and the specific activity of salazopyrine and its metabolite 5-aminosalycilic acid in the ulcerative colitis and refer about the use of drugs as immunodepressors, fatty acids omega 3, zileuton, short chain fatty acids. Practical patterns of therapy in the diverse stages and clinical forms of the disease are exposed.

Substances

MeSH terms

Publication Types